T E Prout|G L Knatterud|C G Meinert - JoVE Visualize

Showing results (11-20 of 68) with videos related to

Pageof 7

Sort By:

Controlled Clinical Trials|December 1, 1987

Patient recruitment experience in the Thrombolysis in Myocardial Infarction TrialG L Knatterud, S A Forman

Blood|January 1, 1983

The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitorsM W Hilgartner, G L Knatterud

Journal of the American College of Cardiology|February 1, 1986

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirinC R Klimt, G L Knatterud, J Stamler, et al.

American Journal of Ophthalmology|September 1, 1980

Sarcoidosis with neovascularization of the optic nerve headM T Doxanas, J S Kelley, T E Prout

Controlled Clinical Trials|August 1, 1997

An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trialP L Canner, B Thompson, G L Knatterud, et al.

JAMA|July 7, 1978

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatmentG L Knatterud, C R Klimt, M E Levin, et al.

Circulation|December 1, 1996

Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB TrialD O Williams, E Braunwald, B Thompson, et al.

Journal of the American College of Cardiology|October 1, 1995

Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI InvestigatorsH S Mueller, S A Forman, M A Menegus, et al.

QJM : Monthly Journal of the Association of Physicians|April 6, 2006

Presenting characteristics as predictors of duration of treatment in sarcoidosisR P Baughman, M A Judson, A Teirstein, et al.

Journal of the American College of Cardiology|December 1, 1990

Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research GroupF Feit, H S Mueller, E Braunwald, et al.

Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:

Pageof 7

Controlled Clinical Trials|December 1, 1987

Patient recruitment experience in the Thrombolysis in Myocardial Infarction TrialG L Knatterud, S A Forman

Blood|January 1, 1983

The use of factor eight inhibitor by-passing activity (FEIBA immuno) product for treatment of bleeding episodes in hemophiliacs with inhibitorsM W Hilgartner, G L Knatterud

Journal of the American College of Cardiology|February 1, 1986

Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirinC R Klimt, G L Knatterud, J Stamler, et al.

American Journal of Ophthalmology|September 1, 1980

Sarcoidosis with neovascularization of the optic nerve headM T Doxanas, J S Kelley, T E Prout

Controlled Clinical Trials|August 1, 1997

An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trialP L Canner, B Thompson, G L Knatterud, et al.

JAMA|July 7, 1978

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatmentG L Knatterud, C R Klimt, M E Levin, et al.

Circulation|December 1, 1996

Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB TrialD O Williams, E Braunwald, B Thompson, et al.

Journal of the American College of Cardiology|October 1, 1995

Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI InvestigatorsH S Mueller, S A Forman, M A Menegus, et al.

QJM : Monthly Journal of the Association of Physicians|April 6, 2006

Presenting characteristics as predictors of duration of treatment in sarcoidosisR P Baughman, M A Judson, A Teirstein, et al.

Journal of the American College of Cardiology|December 1, 1990

Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research GroupF Feit, H S Mueller, E Braunwald, et al.

Pageof 7